Madrigal Pharmaceuticals Inc (MDGL)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$510.67
Buy
$513.58
$-4.91 (-0.95%)
Prices updated at 29 Sep 2026, 17:14 EDT
| Prices minimum 15 mins delay
Prices in USD
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver fa ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $518.67 - $505.69 | |
| $615.00 - $393.61 | |
| - | |
| 11,945.76m | |
| - | |
| - | |
| 52,159 | |
| 22.81 | |
| 334,787.78 | |
| 1.48 | |
| 22.84m | |
| US5588681057 | |
| -12.85 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.